APA

Gram L. F., Brøsen K., Kragh-Sørensen P. & Christensen P. (19891128). Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype. : Therapeutic drug monitoring.

Chicago

Gram L F, Brøsen K, Kragh-Sørensen P and Christensen P. 19891128. Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype. : Therapeutic drug monitoring.

Harvard

Gram L. F., Brøsen K., Kragh-Sørensen P. and Christensen P. (19891128). Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype. : Therapeutic drug monitoring.

MLA

Gram L F, Brøsen K, Kragh-Sørensen P and Christensen P. Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype. : Therapeutic drug monitoring. 19891128.